Benzinga's Top #PreMarket Losers
Sarepta Therapeutics (NASDAQ: SRPT) dipped 48.69% to $18.76 in the pre-market session. Sarepta reported a non-GAAP net loss of $21.3 million, or $0.63 per share. Piper Jaffray downgraded the stock from Overweight to Underweight.
Hanwha SolarOne Co (NASDAQ: HSOL) shares dropped 14.43% to $4.33 in pre-market trading on Q3 results.
Hologic (NASDAQ: HOLX) shares fell 12.66% to $20.00 in the pre-market trading after the company issued downbeat outlook for fiscal 2014. Canaccord Genuity downgraded the stock from Buy to Hold.
JA Solar Holdings Co (NASDAQ: JASO) dipped 3.89% to $11.60. JA Solar's trailing-twelve-month ROE is -24.62%.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.